Abiopharma

🔍 Bharucha Freddy P. (Executive)

Company: PROCTER & GAMBLE Co (PG)

Report Date: 2026-08-06

Detailed Transactions and Holdings:

• Holds 0 shares of Common Stock (Direct)
  Date: 2026-08-06 | Code: H | shares_owned_after: 1,364.15 | Footnotes: F1
• Holds 0 shares of Common Stock (Direct)
  Date: 2026-08-06 | Code: H | nature_of_ownership: By Retirement Plan Trustee | shares_owned_after: 5,623.16 | Footnotes: F2
• Holds 0 shares of Common Stock (Direct)
  Date: 2026-08-06 | Code: H | nature_of_ownership: By Spouse | shares_owned_after: 388.67 | Footnotes: F3
• Holds 0 shares of Common Stock (Direct)
  Date: 2026-08-06 | Code: H | nature_of_ownership: By Spouse, By Retirement Plan Trustee | shares_owned_after: 3,963.00 | Footnotes: F2
• Holds 0 shares of Common Stock (Direct)
  Date: 2026-08-06 | Code: H | nature_of_ownership: By Spouse, International Stock Ownership Plan & Pension Plan | shares_owned_after: 895.98
• Acquired 7 shares of Restricted Stock Units (Derivative)
  Date: 2025-12-03 | Code: A | equity_swap_involved: 0 | shares_owned_after: 16.05 | transaction_form_type: 5 | Footnotes: F4, F5, F5
• Acquired 6 shares of Restricted Stock Units (Derivative)
  Date: 2026-02-17 | Code: A | equity_swap_involved: 0 | shares_owned_after: 22.27 | transaction_form_type: 5 | Footnotes: F4, F5, F5
• Acquired 7 shares of Restricted Stock Units (Derivative)
  Date: 2026-05-15 | Code: A | equity_swap_involved: 0 | shares_owned_after: 29.54 | transaction_form_type: 5 | Footnotes: F4, F5, F5
• Acquired 0 shares of Series A Preferred Stock (Derivative)
  Date: 2026-07-14 | Code: A | equity_swap_involved: 0 | shares_owned_after: 1,241.95 | transaction_form_type: 5 | Footnotes: F6, F7, F7
• Acquired 0 shares of Series A Preferred Stock (Derivative)
  Date: 2026-07-14 | Code: A | equity_swap_involved: 0 | shares_owned_after: 803.12 | transaction_form_type: 5 | Footnotes: F6, F7, F7
• Acquired 789 shares of Restricted Stock Units (Derivative)
  Date: 2026-08-06 | Code: A | equity_swap_involved: 0 | shares_owned_after: 789.00 | transaction_form_type: 4 | Footnotes: F8, F5, F5

Footnotes:

• F1: Total includes grant of dividend equivalents in the form of Restricted Stock Units (RSU's) settled in common stock.
• F2: Reflects adjustment to PST through July 14, 2026.
• F3: Total includes grant of dividend equivalents in the form of Restricted Stock Units (RSU's) settled in common stock and shares acquired through the issuer's dividend reinvestment plan.
• F4: Dividend equivalents in the form of Restricted Stock Units (RSUs) previously awarded pursuant to issuer's retirement program. All such RSUs represent a contingent right to receive Procter & Gamble common stock.
• F5: These units will deliver in shares on retirement from the company, unless delivery is deferred or such shares are contributed to reporting person's deferred compensation account.
• F6: Higher of $6.82 (adjusted for 2-for-1 stock split effective May 21, 2004) or market price of Common Stock.
• F7: Shares held by Retirement Plan Trustees. If Officer terminates employment and elects distribution of shares, or, if after age 50 elects alternative investment within Plan, Preferred Stock converted/redeemed at specified conversion/exercise price.
• F8: Retirement award in the form of Restricted Stock Units which represent a contingent right to receive P&G common stock or cash settlement. Amount and price computed per benefit formula for plan year ended 6/30/2026.